Antibody-drug conjugate

Show results for

Unknown (1480)
Genomics (104)
Transcriptomics (85)
Proteomics (24)
Other (3)
Clinical (1)
Methylation profiling (1)

Organisms

Homo sapiens (104)
Mus musculus (18)
Oncorhynchus mykiss (1)
Macaca mulatta (1)
cellular organisms (1)

Organisms

Homo sapiens (57)
Mus musculus (13)
Macaca mulatta (1)
Escherichia coli (1)

Repository

ENA (91)
geo (74)
biostudies-arrayexpress (18)
pride (15)
EGA (10)
MassIVE (4)
iProX (2)
jPOST (2)
GPMDB (1)

Tissue

Cell culture (7)
Epithelial cell (3)
Permanent cell line cell (2)
B cell (1)
Brain (1)
Cell suspension culture (1)
Colon (1)
Leukocyte (1)
Macrophage (1)
Melanocyte (1)
Monocyte (1)
Plasma cell (1)
Primary cell (1)

Disease

HPV positive (1)
Colorectal Neoplasms (1)
Not Available (1)
Brain glioblastoma multiforme (1)
Breast cancer (1)
Hodgkin's lymphoma (1)
Lung adenocarcinoma (1)
Melanoma (1)
Multiple myeloma (1)
Neck carcinoma (1)
Neuroblastoma (1)

Technology Type

Mass Spectrometry (15)
Shotgun proteomics (8)
Affinity purification coupled with mass spectrometry proteomics (3)
Bottom-up proteomics (3)
Data-dependent acquisition (2)
Top-down proteomics (2)
Data-independent acquisition (1)

Instrument Platform

Illumina NovaSeq X (2)
Orbitrap Fusion Lumos (2)
NextSeq 2000 (1)
Illumina NovaSeq 6000 (1)
Instrument (1)
LTQ Orbitrap Velos (1)
Orbitrap Ascend (1)

Publication Date

2026 (27)
2025 (26)
2024 (18)
2023 (8)
2021 (8)
2015 (5)
2022 (4)
2013 (3)
2017 (2)
2014 (2)
2012 (2)
2011 (2)
2020 (2)
2018 (2)
2010 (1)
2007 (1)
2019 (1)
2016 (1)

First Public Date

2026 (29)
2025 (22)
2024 (17)
2021 (7)
2023 (6)
2020 (4)
2022 (2)
2019 (1)
2018 (1)
2017 (1)
2015 (1)

Classification

bacteria (1)

Study status

Not provided (1)

Study type

Transcription profiling by array (13)
RNA-seq of coding RNA from single cells (3)
CUT&RUN (1)
RNA-seq of coding RNA (1)
Interventional (1)

Release Date

2025 (248)
2023 (204)
2022 (165)
2024 (163)
2021 (155)
2020 (114)
2019 (113)
2018 (96)
2017 (59)
2026 (46)
2016 (35)
2015 (32)
2014 (26)
2013 (18)
2012 (10)
2011 (5)
2010 (2)
2008 (2)
2005 (2)
2007 (1)
2009 (1)
2006 (1)

Lab affiliation

2. Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK (1)
Biomolecular Mass Spectrometry & Proteomics, Bijvoet Center for Biomolecular Research & Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.; Netherlands Proteomics Center, Padualaan 8, 3584 CH Utrecht, The Netherlands (1)
Children's Hospital of Philadelphia (1)
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. (1)
Department of Haematology, University of Cambridge (1)
Department of Nuclear Medicine and Radiobiology Faculty of Medicine and Health Sciences Université de Sherbrooke Sherbrooke, Quebec, Canada (1)
Institute of Biomedical Science, Academia Sinica, Taiwan (1)
Laboratoire de Spectrométrie de Masse BioOrganique (LSMBO), Université de Strasbourg,CNRS, IPHC UMR 7178, 67087 Strasbourg,France (1)
Laboratório Nacional de Biociências, LNBio. Centro Nacional de Pesquisa em Energia e Materiais, CNPEM (1)
Molecular Proteomics Laboratory, Heinrich Heine University Düsseldorf, Düsseldorf, GermanyMolecular Proteomics Laboratory, Heinrich Heine University Düsseldorf, Düsseldorf, Germany (1)
Novartis Isntitutes for Biomedical Research, Cambridge, MA 02139, USA DMP (1)
OncoProteomics Laboratory, Dept of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands (1)
Professor, Department of Cell and Regenerative Biology Professor, Department of Chemistry Director of Mass Spectrometry Human Proteomics Program School of Medicine and Public Health University of Wisconsin-Madison (1)
Seoul National University (1)
The University of Texas at Austin (1)

Location

Italy (1)

Keyword

HERCEPTIN*EV 1FL 150MG (1)
TYVERB*70CPR RIV 250MG (1)
Lapatinib (1)
Ado-Trastuzumab Emtansine (1)
Maytansine (1)
Pertuzumab (1)
Trastuzumab (1)

Previous page
1 / 170
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 170
Next page

Sort by:

Relevance

Page size

Enhanced Characterization of Lysine-Linked Antibody Drug Conjugates Enabled by Middle-Down Mass Spectrometry

HCD Triggered UVPD and EThcD files for characterization of trastuzumab-emtansine (T-DM1)

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2023-08-03 | MSV000092585 | MassIVE

Proteomics analysis of the molecular mechanism by which Antibody-drug conjugate Oba01 combined with Abemaciclib kills colorectal cancer organoids

Proteomics reveals the molecular mechanism by which the antibody-drug conjugate Oba01 and the CDK4/6 inhibitor Abemaciclib jointly kill colorectal cancer organoids

ORGANISM(S): Homo Sapiens (human)

2025-05-03 | PXD063571 | JPOST Repository

TD-MS analysis of single-domain antibody and anti-EGFR single-domain antibody-drug conjugate

Analysis of the intact single-domain antibody and its associated anti-EGFR single-domain antibody-drug conjugate. Optimizations of conditions with various fragmentation methods.

ORGANISM(S): Cellular Organisms

2025-02-11 | PXD058380 | JPOST Repository

A microbial-inspired antibody-drug conjugate for cancer immunotherapy

PRJNA1077275 | ENA

Target identification for 11q13 amplicon

Proteomic strategy to define therapeutically relevant targets in cell lines that contain the 11q13 amplicon compared to those that do not and to ascertain which genes are amplified at the protein level and, concomitantly, are key drivers for tumor growth and/or maintenance. Furthermore, so called p...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2016-07-22 | MSV000080001 | MassIVE

CD276-DM1 Antibody drug conjugate with cmLumiOpto gene therapy to treat triple negative breast cancer.

PRJNA1387216 | ENA

Anti-HIV Immunotoxin and Antibody-Drug Conjugate Targeted by the Same Anti-gp41 Antibody Display Distinct Modes of Cellular Killing

PRJNA1222847 | ENA

RPPA profiling of ES8 Ewing sarcoma xenografts after Endoglin-targeting antibody-drug conjugate treatments

PRJNA472943 | ENA

Identification of MUC1-C Dependence in Drug-Resistant Advanced Prostate Cancer Uncovers a New Target for Antibody-Drug Conjugate Therapy

PRJNA1158796 | ENA

Identification of MUC1-C Dependence in Drug-Resistant Advanced Prostate Cancer Uncovers a New Target for Antibody-Drug Conjugate Therapy

PRJNA1159347 | ENA